Habitu

Habitu
A private, self-adapting platform for clinical trials and patient support in community healthcare.
About
What does Habitu do?
Habitu provides a unique, private, and self-adapting platform designed to enhance clinical trials and patient support programs within community-based healthcare settings. Their solution offers continuous emotional, professional, and procedural support to patients, automatically adapting to their evolving needs.
What is Habitu's revenue?
StartupHub estimates Habitu's annual revenue at $357K (range $259K to $924K, 68% confidence), based on comparable companies in the sector.
Where is Habitu headquartered?
Habitu is headquartered in New York, United States.
When was Habitu founded?
Habitu was founded in 2017.
What industry does Habitu operate in?
Habitu operates in Healthcare, Patient, Clinical Trials, HealthTech, Patient Support Programs, Digital Health.
How many employees does Habitu have?
Habitu has approximately 2 people on record.
Clinical Trial Discovery by ENSCORE.
SomaIQ drafts the interpretation and patient explanation for your review, reducing a 90-minute task to five.
Akylmed is developing an AI-powered platform to streamline medical documentation and administrative tasks for healthcare providers.
Ultimed develops an AI-powered platform to streamline medical imaging analysis and reporting for radiologists.
Docsynapse provides verified doctors a secure space to discuss patient cases with an integrated AI clinical assistant.
AI-powered platform modernizing senior and behavioral health facilities with smart infrastructure and clinical intelligence.
Evidence-backed medical chart review with audit-defensible outputs.
A tamper-evident, independently verifiable audit trail for clinical AI agents, enforcing policy before action.
An entrant is a company tagged Clinical Trials whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.